3rd Quarter - Termination
TAUZIN CONSULTANTS, LLC for SCILEX HOLDING COMPANY
Client
Income
$110,000
Expenses
—
Terminated
Aug 1, 2021
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to fair competition, the generic drug market, drug costs, pain management, non-opioid alternatives, and prior authorization. Also issues related to COVID-19.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROGER AIDAN ADAMS | — |
| MICHAEL DAVID MEIROVITZ | — |
| MIMI SIMONEAUX KNEUER | Legislative Assistant, Legislative Director, Chief of Staff, Rep. Tauzin |
| THOMAS TAUZIN | — |
Medicare/Medicaid MMM
Issues related to fair competition, the generic drug market, drug costs, pain management, non-opioid alternatives, and prior authorization. Also issues related to COVID-19.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROGER AIDAN ADAMS | — |
| MICHAEL DAVID MEIROVITZ | — |
| MIMI SIMONEAUX KNEUER | Legislative Assistant, Legislative Director, Chief of Staff, Rep. Tauzin |
| THOMAS TAUZIN | — |
Affiliated organisations
| Organisation | Location |
|---|---|
| SCILEX PHARMACUETICALS | San Diego, CA, US |
| SEMNUR PHARMACEUTICALS INC. | Mountain View, CA, US |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.